Legal 500
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • News & Developments
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Supplier Code of Conduct
  • Modern Slavery and Human Trafficking Statement
  • Contact Us
  • home
  • Intelligence
  • Search

4,677 results found

Use advanced search filters to refine your search

1 filter applied

Advanced search filters

Topics
Countries
Contributor
Content type
Show options
  • Article

    Draft Regulation Amending Definition Of "Similar Medicinal Product"

    The European Commission has finally published the draft amendment to Regulation No 847/2000 regarding the concept of "similar medicinal product" for the purposes of the Orphan Medicinal Products Regulation.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    New Guidelines On GMP For Advanced Therapy Medicinal Products

    The guidelines are not intended to place any restraint on the development of new technologies.
    European UnionFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    European Court Clarifies The Application Of Procurement Rules To Healthcare

    Last week, the European Court of Justice gave its judgment on certain procurement questions relating to the supply of a radiopharmaceutical product
    European UnionGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Das Einheitspatent – eine (fast) unendliche Geschichte

    Fast war es geschafft: Bis Mitte Juni befand sich das Europäische Einheitspatent nach vielen Jahren und schier endlosen Bemühungen auf der Zielgeraden.
    European UnionIntellectual Property
    Arnold & Porter
    Arnold & Porter
  • Article

    EU Copyright Reform: Article 11 – "Link Tax"

    On 26 March 2019, the European Parliament approved the EU Copyright Directive.
    European UnionIntellectual Property
    Arnold & Porter
    Arnold & Porter
  • Article

    The End Of Intra-EU Roaming Charges

    From today, June 15 2017, European mobile subscribers will be able to ‘roam like at home' and use their home call, text and data allowances in any other European member state at no additional cost.
    European UnionMedia, Telecoms, IT, Entertainment
    Arnold & Porter
    Arnold & Porter
  • Article

    Are Joint Data Control Relationships Now The Norm Rather Than The Exception?

    A recent judgment of the European Court makes it clear that in many circumstances more than one party may be a joint data controller.
    European UnionPrivacy
    Arnold & Porter
    Arnold & Porter
  • Article

    EU Commission Proposes Stronger Mandate For ENISA And EU-Wide Cybersecurity Certification

    The proposal also introduces EU-wide cybersecurity certification schemes for ICT products and services, which will be prepared by ENISA.
    European UnionTechnology
    Arnold & Porter
    Arnold & Porter
  • Article

    Dashefsky And Glantz Discuss New York Market In Legal Business UK

    Lowell Dashefsky, co-head of each of the firm's Private Equity and Life Sciences Transactions practices, and Alan Glantz, co-head of the firm's Syndicated & Leveraged Finance practice...
    GlobalCorporate/Commercial Law
    Arnold & Porter
    Arnold & Porter
  • Article

    Global Anti-Corruption Insights Winter 2017 - Update on Recent Enforcement, Litigation, and Compliance Developments

    2016 also was notable for the level of international cooperation on anti-corruption matters.
    GlobalCriminal Law
    Arnold & Porter
    Arnold & Porter
  • Article

    The Impact Of Artificial Intelligence On Medical Innovation In Europe And United States

    In a recent article published in Intellectual Property & Technology Law Journal, and expanding on our previous post, we discuss the legal and regulatory implications of applying AI to the EU and US healthcare...
    GlobalFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Joint Strike Force Deals A Blow: DOJ Takes Action After U.S.-Origin Components Discovered Inside Russian Weapons Systems And Intelligence Platforms Seized In Ukraine

    Shocking discoveries on the battlefield in Ukraine are sparking national security officials to crack down on illicit international supply chains. Last week, the Department of Justice (DOJ)...
    GlobalGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Monaco Doubles Down: Deputy Attorney General Re-Emphasizes Corporate Crime Enforcement With Focus On National Security, Self-Reporting, And Compensation Incentives

    Deputy Attorney General Lisa Monaco kicked off day two of the ABA White Collar Crime Conference in Miami by doubling down on DOJ's corporate crime enforcement efforts. Monaco announced...
    MonacoCriminal Law
    Arnold & Porter
    Arnold & Porter
  • Article

    Ambassador Barbara Leaf Talks Syrian Leadership Changes With Al Arabiya

    Senior International Policy Advisor and former U.S. Ambassador Barbara Leaf recently spoke to Al Arabiya in a televised segment about regime changes in Syria and the international community's role...
    SyriaGovernment, Public Sector
    Arnold & Porter
    Arnold & Porter
  • Article

    Join The Next Future Pharma Forum: Competition/Antitrust Seminar, 13 June

    The Arnold & Porter Future Pharma Forum provides training and networking opportunities for junior and mid-level lawyers in the life sciences industry.
    United KingdomAntitrust/Competition Law
    Arnold & Porter
    Arnold & Porter
  • Article

    Consultation On Legislative Changes To Support The Rollout Of COVID-19 Vaccines In The UK

    On 28 August 2020, the UK Department of Health & Social Care published a consultation on proposed changes to the Human Medicines Regulations 2012 ("HMRs") to support the rollout of COVID-19 vaccines.
    United KingdomCoronavirus (COVID-19)
    Arnold & Porter
    Arnold & Porter
  • Article

    Back To The Business Of Brexit – What's A "Brexit Clause"?

    Following the result of the UK general election, the upcoming Brexit negotiations, which were due to start in over a week's time, have now been thrown into doubt.
    United KingdomCorporate/Commercial Law
    Arnold & Porter
    Arnold & Porter
  • Article

    European Court Clarifies Use Of Technical Specifications In Healthcare Tenders

    Last week, the CJEU gave its decision in another procurement case in the healthcare area, Case C‑413/17 Roche Lietuva UAB.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    Is Change On The Horizon For The UK Product Liability Regime? [Updated]

    The Law Commission, an independent organisation established to keep the law of England & Wales under review and recommend reform, has announced a review of the law in relation to liability for defective products.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    NICE to Introduce HTA-style App Assessment Process from March 2017

    The National Institute for health and Care Excellence (NICE) provides guidance to the NHS in England on the clinical and cost effectiveness of selected new and established technologies through its healthcare technology assessment (HTA) program.
    United KingdomFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Showing 721–740 of 4677 results

    PreviousNext
    Legal Intelligence Newsletters